Press Release: European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines

Author (Corporate)
Series Title
Series Details EMA/CHMP/112042/2012 (17.2.12)
Publication Date 17/02/2012
Content Type

Aliskiren-containing medicines are approved for the treatment of essential hypertension. ‘Essential’ means that there is no obvious cause for high blood pressure.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/02/news_detail_001446.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp
Related Links
EMA: Press Release: EMA/CHMP/112042/2012 (17.2.12): European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2012/02/WC500122913.pdf
Subject Categories
Countries / Regions